These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 28385820)

  • 1. Principles of diagnosis and management of neuroendocrine tumours.
    Raphael MJ; Chan DL; Law C; Singh S
    CMAJ; 2017 Mar; 189(10):E398-E404. PubMed ID: 28385820
    [No Abstract]   [Full Text] [Related]  

  • 2. Occipital Headache as Initial Manifestation of a Pancreatic Neuroendocrine Tumor.
    Tsoukalas N; Triantafyllidis A; Tolia M; Galanopoulos M; Kostakis ID; Demiri S; Toumpanakis C; Koumakis G
    J Gastrointest Cancer; 2018 Dec; 49(4):501-503. PubMed ID: 28283989
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Öberg K; Knigge U; Kwekkeboom D; Perren A;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii124-30. PubMed ID: 22997445
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis for the gastroenteropancreatic neuroendocrine tumors].
    Komoto I; Imamura M
    Nihon Shokakibyo Gakkai Zasshi; 2014 Dec; 111(12):2263-71. PubMed ID: 25482901
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent updates on grading and classification of neuroendocrine tumors.
    Kim JY; Hong SM; Ro JY
    Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.
    Deppen SA; Liu E; Blume JD; Clanton J; Shi C; Jones-Jackson LB; Lakhani V; Baum RP; Berlin J; Smith GT; Graham M; Sandler MP; Delbeke D; Walker RC
    J Nucl Med; 2016 May; 57(5):708-14. PubMed ID: 26769865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gastroenteropancreatic neuroendocrine tumors : targeted diagnostics and therapy].
    Holzer K
    Chirurg; 2014 Aug; 85(8):731-44. PubMed ID: 25103842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Diarrhea in Patients With Carcinoid Syndrome.
    Naraev BG; Halland M; Halperin DM; Purvis AJ; OʼDorisio TM; Halfdanarson TR
    Pancreas; 2019 Sep; 48(8):961-972. PubMed ID: 31425482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Consensus and controversy of endoscopic diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors].
    Chen H; Chen Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):982-986. PubMed ID: 28900987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment.
    Baur AD; Pavel M; Prasad V; Denecke T
    Acta Radiol; 2016 Mar; 57(3):260-70. PubMed ID: 25855665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
    Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
    J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highlights in GEP-NETs From the 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease: Commentary.
    Iyer R; Hatoum H
    Clin Adv Hematol Oncol; 2016 May; 14(5 Suppl 7):17-9. PubMed ID: 27168109
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroendocrine Tumors.
    Basuroy R; Srirajaskanthan R; Ramage JK
    Gastroenterol Clin North Am; 2016 Sep; 45(3):487-507. PubMed ID: 27546845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic Classification of Neuroendocrine Neoplasms.
    Klimstra DS
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):1-19. PubMed ID: 26614366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs).
    Orgera G; Krokidis M; Cappucci M; Gourtsoyianni S; Tipaldi MA; Hatzidakis A; Rebonato A; Rossi M
    Cardiovasc Intervent Radiol; 2015 Feb; 38(1):13-24. PubMed ID: 25366087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological characterization of gastro-entero- pancreatic neuroendocrine tumors].
    Borka K
    Magy Onkol; 2018 Jul; 62(2):90-97. PubMed ID: 30027936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of positive
    Zilli A; Fanetti I; Conte D; Massironi S
    Clin Imaging; 2018; 49():156-158. PubMed ID: 29529451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive gastro-entero-pancreatic neoplasms.
    Coriat R
    Ann Endocrinol (Paris); 2019 Jun; 80(3):185-186. PubMed ID: 31064660
    [No Abstract]   [Full Text] [Related]  

  • 19. Gastroenteropancreatic Neuroendocrine Tumors.
    Fernandes CJ; Leung G; Eads JR; Katona BW
    Gastroenterol Clin North Am; 2022 Sep; 51(3):625-647. PubMed ID: 36153114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Symptoms and diagnosis of neuroendocrine tumors of the digestive system].
    Gyökeres T
    Orv Hetil; 2011 Mar; 152(10):371-8. PubMed ID: 21354953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.